Cargando…

HbA(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients

BACKGROUND: The diagnosis of diabetes mellitus (DM) is based on either fasting plasma glucose levels or an oral glucose tolerance test (OGTT). Recently, an HbA(1c) value of ≥ 48 mmol/mol (6.5%) has been included as an additional test to diagnose DM. The purpose of this study was to validate HbA(1c)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hjellestad, Iren D, Astor, Marianne C, Nilsen, Roy M, Søfteland, Eirik, Jonung, Torbjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679936/
https://www.ncbi.nlm.nih.gov/pubmed/23705980
http://dx.doi.org/10.1186/1475-2840-12-79
_version_ 1782273040584802304
author Hjellestad, Iren D
Astor, Marianne C
Nilsen, Roy M
Søfteland, Eirik
Jonung, Torbjørn
author_facet Hjellestad, Iren D
Astor, Marianne C
Nilsen, Roy M
Søfteland, Eirik
Jonung, Torbjørn
author_sort Hjellestad, Iren D
collection PubMed
description BACKGROUND: The diagnosis of diabetes mellitus (DM) is based on either fasting plasma glucose levels or an oral glucose tolerance test (OGTT). Recently, an HbA(1c) value of ≥ 48 mmol/mol (6.5%) has been included as an additional test to diagnose DM. The purpose of this study was to validate HbA(1c) versus OGTT as a method to diagnose DM in vascular surgery patients. METHODS: The study population consisted of 345 patients admitted consecutively due to peripheral arterial disease. Sixty-seven patients were previously diagnosed with DM. Glucose levels of OGTT and HbA(1c) values were analyzed in 275 patients. The OGTT results were categorized into three groups according to the World Health Organization 1999 criteria: 1) DM defined as fasting plasma glucose (FPG) ≥ 7.0 mmol/L and/or two-hour value (2-h-value) ≥ 11.1 mmol/L; 2) intermediate hyperglycaemia, which consists of IGT (FPG < 7.0 mmol/L and a 2-h-value between 7.8 mmol/L and 11.1 mmol/L), and IFG (fasting glucose value between 6.1 mmol/L and 7.0 mmol/L with a normal 2-h-value); and 3) normal glucose metabolism defined as FPG < 6.1 mmol/L and a 2-h-value < 7.8 mmol/L. RESULTS: Of the 275 patients on whom OGTT was performed, 33 were diagnosed with DM, 90 with intermediate hyperglycaemia and 152 had normal glucose metabolism. An HbA(1c) value of ≥ 48 mmol/mol (6.5%) detected DM with a 45.5% sensitivity and a 90% specificity compared with the OGTT results. Combining the measurements of the HbA(1c) value with the fasting plasma glucose level (≥7.0 mmol/L) increased the sensitivity to 64%. The total prevalence of DM and intermediate hyperglycaemia was 85% based on HbA(1c) values and 45% based on the OGTT. CONCLUSIONS: Compared with the OGTT the HbA(1c) cut-off value of ≥ 48 mmol/mol (6.5%) had a 45.5% sensitivity to diagnose DM in patients with peripheral arterial disease. OGTT and HbA(1c) categorized different individuals with DM and intermediate hyperglycaemia. The total prevalence of pathologic glucose metabolism was substantially higher based on HbA(1c) values than based on OGTT. The high prevalence of DM and intermediate hyperglycaemia when using HbA(1c) in this study may reflect a high chronic glycaemic burden in patients with peripheral arterial disease. Further studies on vascular surgery patients are needed to identify which method, OGTT or HbA(1c), is the better in predicting DM and future clinical development of vascular disease. TRIAL REGISTRATION: REK vest 14109
format Online
Article
Text
id pubmed-3679936
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36799362013-06-13 HbA(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients Hjellestad, Iren D Astor, Marianne C Nilsen, Roy M Søfteland, Eirik Jonung, Torbjørn Cardiovasc Diabetol Original Investigation BACKGROUND: The diagnosis of diabetes mellitus (DM) is based on either fasting plasma glucose levels or an oral glucose tolerance test (OGTT). Recently, an HbA(1c) value of ≥ 48 mmol/mol (6.5%) has been included as an additional test to diagnose DM. The purpose of this study was to validate HbA(1c) versus OGTT as a method to diagnose DM in vascular surgery patients. METHODS: The study population consisted of 345 patients admitted consecutively due to peripheral arterial disease. Sixty-seven patients were previously diagnosed with DM. Glucose levels of OGTT and HbA(1c) values were analyzed in 275 patients. The OGTT results were categorized into three groups according to the World Health Organization 1999 criteria: 1) DM defined as fasting plasma glucose (FPG) ≥ 7.0 mmol/L and/or two-hour value (2-h-value) ≥ 11.1 mmol/L; 2) intermediate hyperglycaemia, which consists of IGT (FPG < 7.0 mmol/L and a 2-h-value between 7.8 mmol/L and 11.1 mmol/L), and IFG (fasting glucose value between 6.1 mmol/L and 7.0 mmol/L with a normal 2-h-value); and 3) normal glucose metabolism defined as FPG < 6.1 mmol/L and a 2-h-value < 7.8 mmol/L. RESULTS: Of the 275 patients on whom OGTT was performed, 33 were diagnosed with DM, 90 with intermediate hyperglycaemia and 152 had normal glucose metabolism. An HbA(1c) value of ≥ 48 mmol/mol (6.5%) detected DM with a 45.5% sensitivity and a 90% specificity compared with the OGTT results. Combining the measurements of the HbA(1c) value with the fasting plasma glucose level (≥7.0 mmol/L) increased the sensitivity to 64%. The total prevalence of DM and intermediate hyperglycaemia was 85% based on HbA(1c) values and 45% based on the OGTT. CONCLUSIONS: Compared with the OGTT the HbA(1c) cut-off value of ≥ 48 mmol/mol (6.5%) had a 45.5% sensitivity to diagnose DM in patients with peripheral arterial disease. OGTT and HbA(1c) categorized different individuals with DM and intermediate hyperglycaemia. The total prevalence of pathologic glucose metabolism was substantially higher based on HbA(1c) values than based on OGTT. The high prevalence of DM and intermediate hyperglycaemia when using HbA(1c) in this study may reflect a high chronic glycaemic burden in patients with peripheral arterial disease. Further studies on vascular surgery patients are needed to identify which method, OGTT or HbA(1c), is the better in predicting DM and future clinical development of vascular disease. TRIAL REGISTRATION: REK vest 14109 BioMed Central 2013-05-25 /pmc/articles/PMC3679936/ /pubmed/23705980 http://dx.doi.org/10.1186/1475-2840-12-79 Text en Copyright © 2013 Hjellestad et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigation
Hjellestad, Iren D
Astor, Marianne C
Nilsen, Roy M
Søfteland, Eirik
Jonung, Torbjørn
HbA(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
title HbA(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
title_full HbA(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
title_fullStr HbA(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
title_full_unstemmed HbA(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
title_short HbA(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
title_sort hba(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679936/
https://www.ncbi.nlm.nih.gov/pubmed/23705980
http://dx.doi.org/10.1186/1475-2840-12-79
work_keys_str_mv AT hjellestadirend hba1cversusoralglucosetolerancetestasamethodtodiagnosediabetesmellitusinvascularsurgerypatients
AT astormariannec hba1cversusoralglucosetolerancetestasamethodtodiagnosediabetesmellitusinvascularsurgerypatients
AT nilsenroym hba1cversusoralglucosetolerancetestasamethodtodiagnosediabetesmellitusinvascularsurgerypatients
AT søftelandeirik hba1cversusoralglucosetolerancetestasamethodtodiagnosediabetesmellitusinvascularsurgerypatients
AT jonungtorbjørn hba1cversusoralglucosetolerancetestasamethodtodiagnosediabetesmellitusinvascularsurgerypatients